Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Search
No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets open in 3 hours 5 minutes
ALL ORDS
7,303.30
-123.30
(-1.66%)
AUD/USD
0.7050
+0.0090
(+1.29%)
ASX 200
7,064.50
-118.20
(-1.65%)
OIL
111.40
+1.81
(+1.65%)
GOLD
1,840.00
+24.10
(+1.33%)
BTC-AUD
42,759.83
+1,088.08
(+2.61%)
📩 Sign up now
News that makes you smarter and richer... For free.
Get Fully Briefed with Yahoo Finance, delivered straight to your inbox.
Cerevel Therapeutics Holdings, Inc. (CERE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
24.44
+0.82
(+3.47%)
At close: 04:00PM EDT
24.44
0.00
(0.00%)
After hours:
04:24PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Operating expenses
Research development
180,317
161,855
103,303
50,294
Selling general and administrative
61,740
58,243
45,813
33,169
Total operating expenses
242,057
220,098
149,116
83,463
Operating income or loss
-242,057
-220,098
-149,116
-83,463
Total other income/expenses net
-1,027
-5,393
-3,274
-46,433
Income before tax
-242,647
-225,334
-152,166
-128,344
Income tax expense
0
0
-24
45
Income from continuing operations
-242,647
-225,334
-152,142
-128,389
Net income
-242,647
-225,334
-152,142
-128,389
Net income available to common shareholders
-242,647
-225,334
-152,142
-128,389
Basic EPS
-
-
-2.01
-1.01
Diluted EPS
-
-
-2.01
-1.01
Basic average shares
-
-
73,643
127,124
Diluted average shares
-
-
73,643
127,124
EBITDA
-
-217,367
-148,719
-83,286
© 2022 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Privacy Dashboard
Privacy (updated)
About our ads
Terms (updated)